Björklund Pharma AS, a wholly owned subsidiary of Bolna AS, invests exclusively in specialized companies with disciplined reinvestment and proven long-term growth. It channels all new capital into high-quality compounders that expand through bolt-on acquisitions and decentralized management, providing agile growth that complements the resilience of Bolna AS’s core holdings.





Updated 2025-06-15